Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 4 1Phase 2 1Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 3NIH 1INDUSTRY 1INDIV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 2Neoplasms 2Colonic Neoplasms 2Carcinoma, Hepatocellular 2Breast Neoplasms 2Anemia 2Uterine Cervical Neoplasms 1Thyroid Neoplasms 1Stomach Neoplasms 1Smoking Cessation 1Papillomavirus Infections 1Pancreatic Neoplasms 1Pain 1Neutropenia 1Neurotoxicity Syndromes 1Neoplasm Metastasis 1Multiple Endocrine Neoplasia Type 1 1Melanoma 1Lymphoma 1Hypothyroidism 1Human Papillomavirus-Related Cervical Carcinoma 1Hepatitis C, Chronic 1Hepatitis C 1Gastrointestinal Stromal Tumors 1Gallbladder Neoplasms 1Fibrosis 1Fatigue 1Esophageal Neoplasms 1Drug-Related Side Effects and Adverse Reactions 1Diabetes Mellitus 1

Interventions

sofosbuvir-velpatasvir drug combination 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × NIH × Fibrosis × Clear all
NCT03520660 2026-05-22

People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents

National Institutes of Health Clinical Center (CC)

Phase 4 Active not recruiting
121 enrolled
Gastrointestinal

Cardiovascular Diseases, Diabetes Mellitus, Fibrosis, Hepatitis C, Carcinoma, Hepatocellular, Hepatitis C, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡